| 产品名 | |||
| BIRB 796 (Doramapimod) | p38 MAPK | 类风湿性关节炎,克罗恩病,牛皮癣 | Phase 2 |
| Telatinib | HSP (e.g. HSP90) | 胃癌 | Phase 2 |
| Crenolanib (CP-868596) | PDGFR | 胃肠肿瘤,白血病 | Phase 3 |
| Duvelisib (IPI-145, INK1197) | PI3K | 白血病,淋巴瘤 | Phase 3 |
| AZD1480 | JAK | 肝细胞癌,骨髓纤维化 | Phase 1 |
| Neratinib (HKI-272) | HER2 | 乳腺癌 | Phase 3 |
| Ataluren (PTC124) | CFTR | 肌营养不良症 | Phase 3 |
| PHA-665752 | c-Met | 胃癌 | Phase unknown |
| Roscovitine (Seliciclib, CYC202) | CDK | 肺癌,库兴氏病,鼻咽癌 | Phase 2 |
| FG-4592 | HIF | 贫血 | Phase 3 |
| Dacomitinib (PF299804, PF299) | EGFR | 肺癌 | Phase 3 |
| Mocetinostat (MGCD0103) | HDAC | 膀胱癌,淋巴瘤 | Phase 2 |
| Ipatasertib (GDC-0068) | Akt | 胃癌,乳腺癌,前列腺癌 | Phase 2 |
| Abemaciclib (LY2835219) | CDK | 肺癌,乳腺癌 | Phase 3 |
| Silmitasertib (CX-4945) | Others | 胆管癌 | Phase 1/2 |
| Dovitinib (TKI-258, CHIR-258) | FLT3 | 肾细胞癌 | Phase 2/3 |
| SGI-1776 | Pim | 前列腺癌,淋巴瘤 | Phase 1 |
| AZD5363 | Akt | 乳腺癌 | Phase 2 |
| Ralimetinib (LY2228820) | p38 MAPK | 骨髓瘤 | Phase 2 |
| BMS-777607 | c-Met | 胃癌,乳腺癌 | Phase 1/2 |
| Enzastaurin (LY317615) | PKC | 淋巴瘤 | Phase 3 |
| MK-8776 (SCH 900776) | Chk | 白血病 | Phase 2 |
| Fasudil (HA-1077) | ROCK | 脑血管痉挛,脑缺血 | Phase 3 |
